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Abstract: In multiple tissues, the Hedgehog secreted morphogen activates in the receiving cells a
pathway involved in cell fate, proliferation and differentiation in the receiving cells. This pathway
is particularly important during embryogenesis. The protein HHAT (Hedgehog O-acyltransferase)
modifies Hh morphogens prior to their secretion, while HHATL (Hh O-acyltransferase-like)
negatively regulates the pathway. HHAT and HHATL are homologous to Saccharomyces cerevisiae
Gup2 and Gup1, respectively. In yeast, Gup1 is associated with a high number and diversity of
biological functions, namely polarity establishment, secretory/endocytic pathway functionality,
vacuole morphology and wall and membrane composition, structure and maintenance. Phenotypes
underlying death, morphogenesis and differentiation are also included. Paracrine signalling,
like the one promoted by the Hh pathway, has not been shown to occur in microbial communities,
despite the fact that large aggregates of cells like biofilms or colonies behave as proto-tissues. Instead,
these have been suggested to sense the population density through the secretion of quorum-sensing
chemicals. This review focuses on Gup1/HHATL and Gup2/HHAT proteins. We review the
functions and physiology associated with these proteins in yeasts and higher eukaryotes. We suggest
standardisation of the presently chaotic Gup-related nomenclature, which includes KIAA117,
c3orf3, RASP, Skinny, Sightless and Central Missing, in order to avoid the disclosure of otherwise
unnoticed information.
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1. Introduction
The yeast Saccharomyces cerevisiae is a recognised model to enlighten higher eukaryotic molecular
processes, including the ones underlying human pathologies, which are very far from microbial life [1].
Intuitively, we associate yeasts, as microbes, to a planktonic form of life. However, microbes in the wild
live mostly as large communities of cells forming biofilms or colonies, the biology of which remains
largely unknown [2]. A colony or a biofilm displays a proto-tissue complex behaviour [3]. In these
communities, cells organise spatially, morphologically and functionally to ensure the survival of the
group. This implies the outlying orchestrated differentiation and death of cells to complete an efficient
colonisation of the substrate, be it the pulp of a fruit or the surface of medical devices.
Within the large multicellular communities of yeast, cells behave similarly to their higher
eukaryotic counterparts. They are born, grow larger and age while replicating until they senesce
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and die. Alternatively, they may die young, following an apoptotic cell death programme [4,5],
allowing the supply of nutrients to the inner layers of the group [4], located further from the nutrient
richer environment. Additionally, yeast cells may differentiate, shifting from yeast into true or
pseudo-hyphae. These differ morphologically and physiologically [6–8]. The differentiation shift
promotes an invasive behaviour generally associated with strain virulence [9]. Therefore, in contrast to
planktonic growth, the survival strategy is collective [2] and resembles tissues from higher eukaryotes.
Accordingly, large populations of yeast cells are imbedded in an extracellular matrix (ECM) composed
of polysaccharides [10] and a large proteome [11], including many representatives of higher eukaryote
ECM key proteins [11].
In higher eukaryotes, long distance communication between cells is achieved by secreted
signalling proteins, namely from the Hedgehog (Hh) or Wingless (Wnt) pathways. These ligands
interact with specific membrane-resident receptors that trigger a downstream signalling pathway in
the receiving cell. No yeast cell-to-cell molecular communication vehicle has been recognised so far,
although ammonia gradients have been suggested to perform a role in the collective orchestration of
cell behaviour [12]. Moreover, the secretion of quorum-sensing small chemicals has been described in
yeasts and suggested to perform a role in the control of population density [13,14]. Concomitantly,
neither Hh- or Wnt-like pathways have been described in yeasts.
The maturation of the Hedgehog secreted morphogens involves intein self-splicing and C- and
N-terminal lipidation (reviewed by [15]). In S. cerevisiae, there is only one recognised self-splicing
protein that has a Hedgehog-like Hint domain, the endonuclease VDE (PI-SceI), which is required for
gene conversion during meiosis [16]. VDE derives from the splicing of Vma1, the alpha subunit of
the V-ATPase [17], whose human homologue has a role in human breast cancer cell invasiveness [18].
More importantly, the highly homologous yeast proteins Gup1 and Gup2, discovered by our group
in 2000 [19], have two homologues in higher eukaryotes that are responsible for the Hh-secreted
morphogen N-terminal palmitoylation (HHAT/Gup2) [20,21] and the negative regulation of the
pathway (HHATL/Gup1) [22]. Gup1 and Gup2 are members of the MBOAT superfamily of membrane
bound O-acyltransferases [23,24] and are present in all eukaryotic genomes sequenced to date.
Their designation as GUP (Glycerol Uptake Protein) comes from their influence on the performance
of glycerol active transport [19,25], which is actually accomplished by Stl1 [26], meaning that Gup
proteins were often mistaken for the actual permease (e.g., [27]). In animal cells, the nomenclature is
not consistent. In mouse, human or fly cells, both Gup1 and Gup2 are known by numerous aliases
(Table 1). Such ambiguity generated the dispersion of experimental data on these proteins, as well as
the under-interpretation of their roles. In yeasts, the Gup proteins have been implicated in a vast
number of phenotypes from very diverse but fundamental biological/molecular processes, which will
be revised in this work. In mammals and fly, the experimental data are scarcer and more recent. Here,
we review the information available from S. cerevisiae and from another model yeast, the human
commensal/opportunistic pathogen Candida albicans, and complement this with the role of Gup
homologues in the regulation of Hedgehog ligand secretion in higher eukaryotes. Moreover, data on
amino acid sequence comparison throughout model organisms are presented and a harmonising
nomenclature is suggested.
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Table 1. Gup1 and Gup2 aliases in the literature and databases.
Aliases Organism Key References
Gup1 Gup2 Saccharomyces cerevisiae [19,28]
Gup1 - Candida albicans [29]
-
RASP
Drosophila melanogaster
[30]
Skinny Hedgehog [20]
Sightless [31]
Central Missing [32]
HHATL HHAT Mus musculus [22]
HHATL
HHAT Homo sapiens
[33]
c3orf3 [34]
KIAA117 [35,36]
MBOAT3 * [33]
MSTP002 # [33]
OACT3 * [33]
* Nomenclature shared with Xenopus laevis and X. tropicalis; # Nomenclature shared with X. tropicalis.
2. Yeast Gup1 and Gup2 Proteins
2.1. Gup1 and Gup2 Are Members of the MBOAT Superfamily
S. cerevisiae GUP1 was first associated with the recovery of glycerol from the medium for
osmoregulation purposes [19]. In accordance, glycerol active transport is deficient in GUP1-deleted
mutants [19,25]. However, this is an indirect effect, resulting from the involvement of Gup1 in lipid
raft formation [37]. Raft disassembly causes Pma1 H+-ATPase plasma membrane misdistribution [27],
decreasing the appropriate proton motive force for active transporters like Stl1 to work properly [37].
Gup1 has a close homologue Gup2. The two proteins share a high degree of similarity (77%) and
identity (57%) [19]. Gup1 and Gup2 are members of the MBOAT superfamily of multispanning
membrane-bound O-acyltransferases, a superfamily that was first suggested based exclusively
on sequence similarity between a small group of proteins [23]. Besides Gup proteins from
S. cerevisiae, the MBOAT superfamily includes proteins as diverse as mammalian acyl-CoA:cholesterol
acyltransferases (ACAT), fly palmitoyltransferases (Porcn and Nessy), Arabidopsis thaliana diglyceride
acyltransferases (DGAT), bacteria Bacillus subtilis, Staphylococcus aureus and Pseudomonas aeruginosa
D-alanyltransferases (DltB) and alginate O-acetyltransferases (AlgI) [23]. All of these proteins share
a highly conserved histidine residue localised in a hydrophobic domain (His447 in yeast Gup1),
as well as another residue of histidine, asparagine or aspartic acid, localised 30–50 amino acids
upstream, within a hydrophilic region (His411 in the yeast Gup1). These conserved positions specify
the active centre of these enzymes. The MBOAT superfamily is presently subdivided into three
functionally different subgroups. One group includes enzymes involved in neutral lipid biosynthesis
(ACATs and DGATs), another group includes proteins involved in phospholipid remodelling
(lysophosphatidate acyltransferases—LPATs) and a third group includes the enzymes implicated
in protein acylation (Porcupine (from the Wnt pathway), HHAT(L) (from the Hh pathway) and
Ghrelin O-acyltransferase—GOAT (from the insulin regulatory pathway)) [38]. Gup1, although
included in the third group, has also been included in the LPATs group due to the multiple biological
and molecular roles assigned to it. In the mammalian HHAT(L), the highly conserved MBOAT
signature amino acid residues are different. The yeast Gup1 His411/His447 and Gup2 His461/His498
positions are occupied by aspartic acid and histidine in HHAT and by aspartic acid and leucine
in HHATL, respectively. Interestingly, the substitution of His447 by a leucine in S. cerevisiae Gup1
caused loss of phenotype [39], raising the question whether mammalian HHATL actually functions
as an acyltransferase [22]. The roles attributed to Gup1 in all cellular models are for now exclusively
biological/phenomenological, not biochemical. In contrast, the HHAT from high eukaryotes has a
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fully recognised enzymatic function in the N-palmitoylation of the Hh-secreted signals that can be
reproduced in vivo and in vitro [21,40]. The yeast Gup2 shares with Gup1 the two MBOAT conserved
histidines in the amino acid sequence positions 460 and 496.
According to the most common algorithms used to calculate the hydrophobicity of amino acid
sequences, the Gup1 and Gup2 proteins both have 10 well-defined transmembrane domains (TMD).
This number of TMD implicates that Gup1 terminals are both located on the same side of the membrane.
However, the Gup1 C- and N-terminal domains are localised, respectively, in the periplasmic and
cytosolic sides of the membrane [41], which is a rather uncommon topology. HHAT from mammals
has a re-entrant loop stabilised by a lipid attachment, a palmitoylation of the MBOAT aspartic acid
signature (Asp339) [42]. This re-entrant loop actually comprises both MBOAT signature amino acids
(M. musculus Asp339 and His374; H. sapiens Asp340 and His377). S. cerevisiae Gup1 and Gup2 and
C. albicans Gup1 present a partially hydrophobic region, located between TMD 7 and 8 (using the TMD
prediction engine available at [43]). The correspondent sequence aligns perfectly with the sequence
from the M. musculus HHAT re-entrant loop, showing several conserved several amino acid residues.
In silico palmitoylation prediction of Gup amino acid sequence (using the prediction engine available
at [44]) indicates a fully conserved cysteine residue in that region: S. cerevisiae Gup1 Cys396 and Gup2
Cys445; C. albicans Gup1 Cys417; M. musculus HHAT Cys324 and HHATL Cys326; H. sapiens HHAT
Cys325 and HHATL Cys326; and D. melanogaster RASP Cys326. This degree of conservation, in addition
to the possibility that a palmitoylation is involved, suggests that Gup proteins might require the
MBOAT signature residues to be embedded in or at the surface of the membrane, whether this is
obtained by Cys or Asp palmitoylation as in mammalian HHAT [42]. This possibility will have to be
studied in the future.
2.2. Gup1 and Gup2 Subcellular Localisation
In S. cerevisiae, Gup1 protein co-localises with markers of the plasma membrane, the endoplasmic
reticulum (ER) and the mitochondria [19]. Gup2 shares the first two locations [45]. The more prominent
localisation of Gup1 appears to be the plasma membrane, as revealed by GFP tagging at either N- or
-C-terminal [41]. The plasma membrane localisation of Gup1 is dependent on the secretory pathway
proteins Sec6-4 [41] and End-3-mediated excision [26,41]. In opposition, in mammalian cells (mouse
myocytes cell line), the Gup1 orthologue localises predominantly in the cytosol and only residually in
the ER closer to the nucleus [34].
2.3. GUP1 and GUP2 Expression in Yeast
The yeast GUP2 promoter displays consensus sequences for 65 transcription factors (TF),
and GUP1 for 19 TF (Table 2; [46]). These include major players in yeast transcription control,
like the general stress regulators Msn2 and Msn4, the glucose-repression controller Mig1, Ste12
from pheromone response and mating and Gcn4 from nitrogen-associated regulation. Three TFs are
predicted to regulate both promoters identically (Tec1, Mig3 and Rap1), and one—Ash1—is predicted
to activate GUP1 and inhibits GUP2 transcription (Table 2).
The presence of numerous TF consensus sequences in yeast GUP1/2 promoters could reflect
a complex transcription regulation, yet GUP1 and GUP2 are almost invariantly expressed in
several different conditions. This is the case for cells actively growing on glucose (repression
conditions—fermentation) and on glycerol or ethanol (de-repression conditions—respiration) [47],
as well as in cells adapted to osmotic stress conditions created by high amounts of salt [47,48],
or subjected to osmotic shock by high amounts of sorbitol [49]. These results suggest that the expression
of these genes might be constitutive [47]. Nevertheless, this cannot be the case since GUP1 transcription
duplicates upon NaCl shock [50]. Additionally, at the level of the protein, Gup1 is stably internalised in
an End3-dependent manner upon sudden shift from glycerol to glucose [26,41]. Glycerol has multiple
and complex roles in yeast cells. It is a respired poor carbon source whose metabolism requires
induction and relief from glucose-repression. It functions as an osmolyte (reviewed by [51]), a lipid
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synthesis precursor [52], a pendulum of the NAD(H) redox balancing cytosol/mitochondrial shuttle [53],
and is necessary for maintaining the signalling competent state of the cells [54]. The fact that Gup1 is
retrieved from the plasma membrane upon glycerol-to-glucose transition, and overexpressed upon salt
shock when glycerol accumulation is required for cell survival [51], establishes a connection between
Gup1 and glycerol-associated regulation, which nature keeps unknown.
Table 2. Documented transcription factors that function as regulators of Gup1 and Gup2 [46].
Activ.: activator; Inhib.: inhibitor.
Predicted Function in GUP1 and GUP2 Transcription Regulation
GUP1 GUP2 Identical Regulation Opposite Regulation
Activ. Inhib. Both Activ. Inhib. Both Activ. Inhib. Both Activ. GUP1+ Inhib. GUP2
Inhib. GUP1
+ Activ. GUP2
Ash1 Abf1 Rap1 Ecm22 Sfp1 Ace2 Aft1 Tec1 Mig3 Rap1 Ash1 none
Met4 Cac2 Spt23 Gat4 Snf2 Ash1 Cbf1
Tec1 Cup9 Yrm1 Gcr2 Snf6 Bas1 Cin5
Gal4 Gis1 Sok2 Fhl1 Plm2
Hir3 Gln3 Spt10 Gcn4 Pho4
Mig3 Gzf3 Spt2 Gcr2 Rap1
Sfp1 Hap5 Ste12 Mig3 Rfx1
Sum1 Hda1 Sut1 Msn4 Sko1
Uls1 Hms1 Swi3 Rif2 Xbp1
Isw2 Taf14 Set2 Yap6
Mbp1 Tec1 Swi5 Msn2
Mcm1 Tup1 Tbf1 Swi4
Mga1 Uls1
Mig1 Uc2
Mot3 Urc2
Nrg1 Xbp1
Rgm1 Yhp1
Rox1 Yox1
YR015C
Observations: Ash1: TF inhibitor of HO transcription; Mig3: TR with a major role in catabolite repression
and ethanol response; inactivated by phosphorylation by Snf1 or Mec1 pathway; Rap1: Essential TR for many
loci: transcription activation and repression, chromatin silencing, and telomere length maintenance; Tec1:
TF targeting filamentation genes and Ty1 expression; activity dependent on association with Ste12; Ste12
activation of most filamentation gene promoters depends on Tec1.
GUP2 is generally less expressed than GUP1 [47], and gup2∆ null mutants do not present any
marked phenotype in response to carbon sources (glucose/glycerol) or stress (salts, ethanol, weak acids
and high temperature). In contrast, gup1∆ mutants are moderately sensitive to all stresses [28] with
the exception of high temperature, to which gup1∆ is highly sensitive [28,55]. The expression of GUP2
(not GUP1) has been shown to increase considerably upon ultraviolet irradiation [56], leading the
authors to suggest Gup2 as part of the Early Genotoxic Response, i.e., the response to metal poisoning.
Up-regulation of Gup1 induces the up-regulation of several genes resident in the ER and Golgi,
from the secretory pathway and lipid synthesis [39]. Kar2, a key protein from the Unfolded Protein
Response (UPR) signalling pathway, stands out for its 24-fold increased expression [38]. Up-regulation
of Gup1 further induces proliferation of membranous cisternal structures, with 1–7 per cell, physically
separated from each other. This phenomenon is dependent on Ire1, another protein from the UPR
pathway. ER, Golgi and itinerant proteins are present in these structures. Gup1 was also found,
appearing to diffuse in and out of these structures [39]. Remarkably, the production of these membrane
structures is dependent on the H447 MBOAT signature amino acid.
3. Yeast Phenotypes Associated with the Deletion of GUP1
3.1. Phenotypes Emerging from Genome-Wide Yeast Screenings
The extensive list of phenotypes associated with the deletion of GUP1 comprises many that were
obtained in genome-wide screening. These include cytoskeleton polarisation and bud site selection
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patterns [57,58], secretory and endocytic pathways [59], vacuole morphology [59] and anaerobic
growth [60]. Other high throughput studies cannot be presently rationalised, namely Askree et al. [61],
which mentions Gup1 as an important protein in the maintenance of proper telomere length.
Importantly, many of these studies show the resistance of the gup1∆ mutant to pharmaceutical drugs
such as the anti-tumoral imatinib [62], the cytostatic cisplatin [63], the anti-inflammatory ibuprofen [64],
the immunosuppressant FK506 [65] and the antimicrobial thymol [66]. Further resistance associated
with GUP1 deletion includes lithium [67] and arsenic [68]. This large list, by itself, suggests an
equally large complexity of Gup1 functions. In contrast, GUP2 has been referred to in only two HTP
screenings [69,70]. The few evidences show that GUP2 expression is increased in response to ethanol
stress in wine fermentative conditions/strains.
3.2. Cell Wall Integrity and Biogenesis
As mentioned above, gup1∆ is very sensitive to high temperature [28,55]. Generally, the sensitivity
of yeast to high temperature is correlated with major defects in cell wall. Consistently, the deletion of
GUP1 in S. cerevisiae causes an increase in the cell wall content of β-1,3-glucans (+25%) [28] and chitin
(+90%) [28,71], and a decrease in the amount of mannoproteins (−70%) [28]. These large differences are
responsible for a deficient wall morphology and sensitivity to wall-perturbing agents [28]. In spite of
these defects, the Cell Wall Integrity (CWI)/PKC pathway is signalling normally in the gup1∆ mutant,
as seen by MAPK (Slt2) (Figure 1A) dually phosphorylated state [28,72] after induction of the pathway
by hypo-osmotic shock [28] or high temperature, or by NaCl or ethanol stress [73].
The CWI/PKC pathway controls not only the biogenesis of cell wall constituents and their
remodelling, but also the associated organisation of the actin cytoskeleton and secretory pathway
(reviewed by [74]). Unlike mammalian cells, S. cerevisiae only has one protein kinase C (Pkc1) that
responds to the G-protein Rho1, the yeast homologue of RhoA. Rho1 activates Pkc1 besides other
effectors. This allows the coordinated control of the actin cytoskeleton, exocytosis, membrane fluidity
and the synthesis of wall glucans through transcription regulation in response to nutrients and
stress [75]. Rho1 in turn is activated by Rom2/1 GDP/GTP exchange factors. These respond directly
at least to a couple of wall stress sensors, Wsc1 and Mid2, and are further activated by the ligation of
PI(4,5)P2 (phosphoinositol biphosphate) and/or of Slm1/2 proteins. The latter are targets for TORC2
(Target of Rapamycin 2 (TOR2) Complex) phosphorylation [76]. TORC2 also directly activates Pkc1,
inducing the PKC pathway response. Importantly, Rho1 and consequently the PKC pathway are also
activated by the α-factor plasma membrane receptor Ste2, a physical partner of Gup2 (Saccharomyces
Genome Database). Rho1 is a signalling node, regulating many proteins and being under the effect of
many others (including Kog1 from TORC1 (Target of Rapamycin 1 (TOR1) Complex) [77]), and it acts
on actin cytoskeleton, thus causing cellular shape/polarity and filamentation [78].
TORC2 is redundant with TORC1 in the control of major cellular functions, but the cell wall
composition and integrity and the polarisation of the actin cytoskeleton associated with cell growth,
division and morphogenesis is only dependent on TORC2 [79,80]. Even though TOR proteins are
very similar phosphatidylinositol kinase (PIK)-related kinases, only TOR1 is sensitive to inhibition
by caffeine or the immunosuppressant rapamycin (reviewed by [80]). The gup1∆ mutant, both alone
and in combination with gup2∆, is resistant to rapamycin [73]. On the other hand, gup1∆ is equally
sensitive to caffeine as the wild type strain but, unlike this last, its sensitivity is remediable with
sorbitol [28].
The mechanisms of action of caffeine and rapamycin are poorly understood. Both induce Rho1
activation and depend on this induction to inactivate the TORC1 pathway [77]. Caffeine induces
the activation of Slt2 in a Tor1/Rom2 dependent manner [81] and elicits a transient decrease in
the intracellular levels of cAMP, concomitantly inhibiting the Ras/cAMP pathway [81]. Moreover,
caffeine supposedly activates the Pkc1 cascade through Tor1-mediated signalling [81]. Rapamycin,
on the other hand, represses rRNA transcription and induces arrest of translation and cell cycle at
G1. Furthermore, it causes glycogen accumulation, sporulation and autophagy [82]. These effects
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demand the complexation of rapamycin with Fpr1 (yeast equivalent of the immunophilin FKBP12)
and subsequently with TOR1 [83]. Resistance to rapamycin in S. cerevisiae, can be provided by Fap1,
which compets with Fpr1 [83,84]. However, the way in which Gup1 might be involved remains obscure.
J. Dev. Biol. 2016, 4, 33 7 of 34 
 
and subsequently with TOR1 [83]. Resistance to apamycin in S. cerevisiae, can be provided by Fap1, 
which compets it  Fpr1 [83,84]. However, the way in which Gup1 might be inv lved remains 
obs ure. 
 
Figure 1. Major players implicated in the phenotypes associated with the deletion of GUP1 in S. 
cerevisiae and C. albicans (grey boxes). Plain arrows indicate established interactions; dashed arrows 
indicate possible interactions. Pentagons refer to nodal proteins exerting multiple signalling, 
affecting positively or negatively many other proteins. (A) The Sho1 downward cascade belongs to 
the HOG (High Osmolarity Glycerol) pathway, and the Rom/Rho cascade constitutes the Cell Wall 
Integrity—CWI/PKC pathway. Crosstalk between HOG, PKC, the complex lipids and TORC1/2 
signalling pathways relevant for GUP1 associated phenotypes is shown; (B) Centrality of Cdc42 
phosphorylation (pink boxes) in the control of pathways ultimately promoting differentiation, 
polarity, growth and reproduction. The central role of one protein shared by many pathways is 
designated in the text as star-type pathway. 
Bearing in mind that the deletion of GUP1 causes defects in cell wall [73], membrane [37,55] and 
endocytosis [59], the cause of resistance to rapamycin could be the inability of the drug to enter the 
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Figure 1. Major players implicate i t e phenotypes associated wit the deleti n of GUP1 in
S. cerevisiae and C. albicans (grey boxes). Plain arrows indicate established interactions; dashed
arrows indicate possible interactions. Pentagons refer to nodal proteins exerting multiple signalling,
affecting positively or negatively many other proteins. (A) The Sho1 downward cascade belongs to
the HOG (High Osmolarity Glycerol) pathway, and the Rom/Rho cascade constitutes the Cell Wall
Integrity—CWI/PKC pathway. Crosstalk between HOG, PKC, the complex lipids and TORC1/2
signalling pathways relevant for GUP1 associated phenotypes is shown; (B) Centrality of Cdc42
phosphorylation (pink boxes) in the control of pathways ultimately promoting differentiation, polarity,
growth and reproduction. The central role of one protein shared by many pathways is designated in
the text as star-type pathway.
Bearing in mind that the deletion of GUP1 causes defects in cell wall [73], membrane [37,55] and
endocytosis [59], the cause of resistance to rapamycin could be the inability of the drug to enter the cell.
Rapamycin is practically insoluble in water and poorly soluble in ethanol or glycerol [85]. This, together
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with its large molecular mass (≈900 Da), suggests an endocytic entrance. Additionally, gup1∆ is also
resistant to the calcineurin inhibitor FK506 [65]. In mammalian cells, this immunosuppressant drug
binds to FKBP12 inhibiting the Ca2+ signalling. Actually, FKBP12 bridges FK506, calcineurin and IP3
(inositol 3-phosphate) receptor, promoting the dephosphorylation of the latter, thereby modulating
Ca2+ flux and signalling [86]. In yeast, FK506 affects the Ca2+-mediated response to high temperature,
high NaCl-osmotic stress and α-factor pheromone [87]. High temperatures and high sodium,
as discussed above, cause severe phenotypes in gup1∆ [19,28], while α-factor secretion is higher
in gup1∆ [59].
The regulatory roles of phosphoinositides in yeast are not as well understood as in higher
eukaryotes [88]. Still, their synthesis and turnover pathways are genetically characterised and the
effects of some of the enzymes on major cellular processes have been recognised. At least seven
unique second-messenger molecules are generated that regulate growth, differentiation, cytoskeletal
rearrangements, membrane trafficking and protein vacuole sorting [88]. The phosphoinositide
signalling operates in yeast as a star-type pathway, i.e., by cross-talking with numerous other pathways
controlling their associated transcription, thus promoting the orchestrated cellular response to
numerous stimuli. Major effectors associated with phosphoinosides in yeast belong to TORC2 and
PKC pathways.
Yeast TOR pathways respond to carbon and nitrogen availability [89]. In silico analysis of
the promoter regions of both GUP1 and GUP2 unveiled a series of putative regulatory sequences,
from which the presence of repeated consensus sequences for Gcn4, a major transcription factor
that responds to amino acid starvation and nitrogen in the dependence of TORC1, stands out [90].
Accordingly, wild-type strain and gcn4∆ mutant expressing lacZ reporter constructions for GUP1 and
GUP2 promoter regions showed that β-galactosidase activity depended on Gcn4 for full expression of
the GUP1 but not GUP2 in synthetic medium. If the medium is supplemented with 0.5% ammonium
sulphate and 15 mM glycerol, the expression of Gup1 in gcn4∆ reverts to the values of wild-type
strain [73]. The gup1∆ mutant dual dependence on nitrogen source and glycerol suggests an intricate
position of the Gup1 protein in the midst of crossroads of N and C regulatory pathways. Moreover,
the operationality of PKC signalling observed in the gup1∆ mutant suggests that the TORC2 pathway
is not affected by the function of Gup1 protein. However, as discussed below, many of the cellular
functions controlled by TORC2 are defective in the absence of GUP1. Besides wall damage-associated
phenotypes, the most striking of these is the altered polarity during division exhibited by gup1∆
mutant [57,58].
The gup1∆ was found to display profoundly aberrant random bud site selection [57,58,76].
This implies a large defect on the proper establishment of cytoskeleton polarity [91,92], which is
known to depend on Rho1/Pkc1 signalling [78]. It is as well dependent on other pathways associated
with the multiple roles of the signalling node Cdc42 [93] (Figure 1B), including the Sho1 branch of
the HOG pathway [94]. Cdc42 has the same fundamental role in mammalian cells (Figure 1B).
This intricate crosstalk implicates the coordinated control of actin cytoskeleton remodelling for
directional growth (elongation), which is mandatory for cell division through budding or mating.
However, more importantly, underlies the morphogenic switch into filamentation that mediates
invasion and adhesion [6,95].
3.3. High Osmolarity Glycerol (HOG) Pathway
In spite of the GUP1 deletion, the CWI/PKC pathway is working properly at the level of Slt2
phosphorylation when stimulated by hypotonic shock [28]. Nevertheless, the wall of the mutant is
severely affected. Two other pathways contribute to the wall integrity and remodelling: the Sho1
branch of the HOG pathway, and the Long-Chain Base (LCB)/sphingolipids YPK pathway (Figure 1A).
HOG stands for High Osmolarity Glycerol, a name derived from control of the production and
accumulation of the yeast osmolyte glycerol in response to high osmotic stress (reviewed by [51]).
The HOG pathway controls many other processes such as polarity, adhesion and invasiveness,
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filamentation (i.e., differentiation), mating and cell wall biogenesis (reviewed by [96]). Importantly,
the HOG pathway is functionally equivalent to the mammalian Wnt/p38 stress responsive MAPK
pathway (Figure 2) [97,98]. Null mutants from HOG pathway have been successfully complemented
by murine [99] or human p38 and associated kinases [100,101]. The p38 pathway is a non-canonical
branch of Wnt MAPK, as are the JNK and ERK5 branches. Nevertheless, it has been shown to
crosstalk with the Wnt canonical ERK1/2/β-catenin branch [102]. Actually, the four Wnt branches
(ERK1/2, p38, JNK and ERK5) are all partially redundant in the control of growth/proliferation,
i.e., cell cycle progression, differentiation, adhesion, migration and apoptosis in response to growth
factors, cytokines and stress (reviewed by [103,104]). The HOG pathway Sho1 sensor functions in
an exceptionally complex manner [105]. It binds to effectors that deliver different responses: Msb2
binds to Cdc42, activating the Ste11/Ste7/Fuss3/Kss1 filamentation/mating and cell wall biogenesis
pathway, and Hkr1 or Opy2 that activate the HOG pathway (Figures 1 and 2) [105,106].
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e strains without GUP1 are unable to gr w under high osmotic stress [19,28]. This could indicate
a malfunction of the HOG pathway and a concomitant deficient production and/ r accumulation
of glycerol. Hyperosm tic stress als stimulates the CWI/PKC pathway [107], a fact that is not
surprisi g since the adaptation to high osmotic stress implicates changes in cell volume a d turg r that
demand remodelling of the cell wall. The simultaneous activation of HOG and CWI/PKC pathways
can also result from other stim li, such as high temperature [108] and the action of zymolyase,
an enzyme cocktail with β1,3-glucanase activity [109,110]. gup1∆ is extremely sensitive to both of these
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stimuli [28]. The effect of zymolyase is particularly severe, namely in comparison with lyticase, another
wall disrupting enzyme [28]. This severity could be the consequence of the increased percentage
of β1,3-glucans in the mutant cell wall. The malfunction of HOG rather than CWI/PKC pathway
was also inferred from the pronounced phenotype of gup1∆ mutant in the presence of Calcofluor
White [28] compared to Congo Red, which caused a negligible defect [111]. While some insults to the
cell wall like Congo Red only trigger CWI/PKC [81,112], others trigger both HOG and CWI/PKC
pathways [107–110]. In spite of the intricate interplay between both pathways (reviewed by [107]) the
phenotypes caused by GUP1 deletion associated with osmoregulation [19] and the cell wall [28] are
consistent with a relation of Gup1 with both pathways.
3.4. Plasma Membrane Composition and Associated Signalling
Gup1 is implicated in several membrane and lipids associated phenotypes [37,55,60,113].
The signalling pathway associated with complex lipids, the LCB/sphingolipid YPK pathway (partially
depicted in Figure 1A), is not very well studied in yeasts, and no parallel has been established with
the mammalian counterpart. The activation of Ypk1/2 is dependent on phosphorylation by Pkh1/2
kinases [114,115] or by TORC2 [115,116]. Pkh1/2 responds to LCBs and is implicated in membrane
trafficking events. These include endocytosis through Pkc1-associated actin remodelling [114],
protein phosphorylation [117], the trafficking of glycosylphosphatidylinositol (GPI)-anchored proteins,
and the cell surface expression of amino acid permeases [118]. In mammalian cells, sphingosine acts as
an inhibitor of PKC, or as activator of casein kinase II, Pkcζ, Pak1 (p21-activated kinase) and PDK1
(phosphoinositide-dependent kinase 1) (reviewed by [119]).
The lipid membrane composition and rafts content have implications in membrane
fluidity/rigidity. In this regard, membrane fluidity homeostasis has been suggested to be under
the control of a novel pathway that involves Rho1 effector [75]. According to these authors, the overlap
between the CWI pathway with the membrane fluidity homeostasis pathway includes at least six
components: Rho1, Pkc1, Bck1, Mkk1, Mkk2, Slt2 and Swi6. This is comparable to the overlap
between mating response, pseudohyphal growth and the HOG pathways [107]. Membrane fluidity
depends ultimately on the amount of complex lipids. Accordingly, the depletion of sphingolipids
elicits the activation of TORC2 through Ypk1/2 and Orm1/2 that in turn stimulate their synthesis
(Figure 1A) [120].
Down-regulation of TORC2-Ypk1 signalling allows cell survival under high osmotic stress
independently of HOG pathway activation [121]. TORC2-Ypk1 signalling operates through closing of
the glycerol channel Fps1, by blocking its phosphorylation by Ypk1. This is crucial to maintain the Fps1
channel open in the absence of stress [121]. This TORC2-Ypk1-mediated control occurs independently
of the control of the channel by Hog1 [122]. Moreover, the enzyme responsible for deviating the
glycolytic flux towards glycerol production Gpd1 (cytosolic glycerol 3 phosphate dehydrogenase) is
also a target for Ypk1/2 [122], while its mitochondrial isogene Gpd2, from the glycerol NAD(H) shuttle,
is under the direct control of glucose and is activated by phosphorylation via the AMP-activated kinase
Snf1 [122]. Moreover, glycerol consumption and active uptake through Stl1 permease [26] is severely
affected by the absence of PKC1 [123]. This strengthens the notion that glycerol is a major driver in
maintaining the signalling competent state of cells, as suggested before [54], namely in the crossroads
of responses to nutrients availability and stress through TORC2, sphingolipids, CWI/PKC and HOG
pathways. The defects caused by GUP1 deletion appear in the centre of this puzzle, suggesting a
pivotal role in signalling for the Gup1 protein.
LCB/sphingolipids form Detergent-Resistant Microdomains (DRM) in the plasma membrane, also
known as lipid rafts due to their particular molecular/physicochemical properties. These properties
derive from the predominantly saturated hydrocarbon tails of the sphingolipids and the high
concentration of sterols: cholesterol in animal cells (e.g., [124]) and ergosterol in yeasts [125,126].
In yeast, as in mammalian cells, lipid rafts participate in protein sorting (contributing to the functions
of transporters, pumps, sensors, receptors or G-proteins), dynamically including or excluding
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proteins [127–129]. Importantly, the components of lipid rafts are also actively involved in signalling
and in stabilization of actin cytoskeleton–membrane interactions and therefore polarity [128,129].
In yeast, many proteins are known to functionally localise in lipid rafts forming a complex
patchwork [128], which biogenesis is still poorly known. The first proteins found in yeast membrane
microdomains were the H+-ATPase pump Pma1 [130] and the amino acid permease Can1 [131].
Presently, almost 300 proteins have been found to differentially localise into lipid rafts [128], including
many permeases involved in ion homeostasis, water, glycerol or drugs transport as well as sugar or
nitrogen transport/sensing, cell wall metabolism, stress response, signalling, flocculation, bud site
selection and eisosome formation. Some are GPI-anchored like the β1,3-glucanosyltransferase
Gas1 [125], while others are prenylated, or farnesylated and palmitoylated like Ras2 [132], but most
just have transmembrane domains (see [128] for a comprehensive list). Different types of membrane
lipid microdomains were identified and designated identified on the basis of the proteins they harbour:
Membrane Compartment occupied by Pma1 (MCP), Can1 (MCC) [131] or TORC2 (MCT) [133].
The plasma membrane localisation of Gup1 [19,41] and Gup2 [45] has not been associated with
raft residence [128]. Still, a patchy distribution of the labelled Gup1 protein was observed by electron
microscopy [41]. Importantly, gup1∆ is affected in lipid rafts integrity and assembly [37]. This was
evidenced by the even, not punctate, distribution of sterols in the mutant plasma membrane, as well
as the 40% lower amounts of DRM recovered [37]. Additionally, Pma1 (H+ pump known to reside in
lipid rafts, specifically MCPs [128]) is absent from gup1∆ DRMs, and the amounts of Gas1 (the most
abundant yeast GPI-anchored protein) are residual, suggesting that rafts were unselectively affected by
GUP1 deletion [37]. Accordingly, Gup1 interferes in sterol and sphingolipids synthesis, as evidenced
by respectively increased and decreased resistance of the mutant to inhibitors of specific biosynthetic
steps [37].
The yeast cell is a facultative anaerobic organism that can efficiently endure environments with
virtually inexistent oxygen. In these conditions, the yeast cell does not synthesise sterols. Instead,
it must take up sterols from the environment using the Pdr11 ATP-binding cassette (ABC) multidrug
transporter [134], another permease known to locate in lipid rafts [128]. GUP1 was found to be crucial
for survival in anaerobiosis [63]. In gup1∆, not only is the biosynthesis of sterols affected, but also the
uptake of sterols is impaired, underlying its inability to grow in anaerobic conditions [60].
Yeast lipid rafts assembly, unlike mammalian counterparts, takes place in the ER,
only subsequently stepping into the Golgi [125]. Moreover, MCPs and MCCs are likely to segregate
differently, since Pma1 is only incorporated into the rafts outside the ER [130]. ER resident proteins
targeted to sphingolipids/ergosterol-poor membranes, such as the vacuole membrane, are not involved
in rafts assembling [129]. Therefore, the defect in rafts assembly generated by GUP1 deletion must occur
in the ER (one of Gup1 localisations) and may induce the segregation of specific membrane/protein
assemblages towards their correct location. Another group of results concurs for a clear implication
of the Gup1 protein in the secretory/endocytic pathways. In yeast, the vacuole performs the role of
mammalian lysosomes. Proteins are addressed to the vacuole for degradation by the same pathway as
carboxypeptidase Y (CPY), through the late endosome (reviewed by [135]). GUP1 was identified as
one of the genes required for efficient sorting of CPY to the vacuole, as well as for the maintenance
of this organelle regular size and morphology [59]. Its deletion also causes the excessive secretion
of α-factor [59], the ER-resident protein Pdi1 [28], and the GPI-anchored β1,3-glucanosyltransferase
Gas1 [37].
The deletion of GUP1, besides affecting sterols and sphingolipids synthesis and impairing sterols
uptake, also causes changes in the regular concentrations of major lipid types: a high increase in diacyl-
and triacylglycerol (Figure 3A) and a decrease in phospholipids [55]. Fatty acids synthesis, on the other
hand, remains normal [37]. However, Gup1 is not recognised as an enzyme from lipid biosynthesis
pathways. In this regard, Bosson and co-workers [113] proposed the involvement of Gup1 in the GPI
synthesis/remodelling process, which occurs at the level of the ER in S. cerevisiae [136,137]. The anchors
of mature GPI-anchored proteins of S. cerevisiae contain either ceramide or diacylglycerol with a C26
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fatty acid in the sn2 position [138,139]. Gup1 was proposed to be the enzyme that adds C26 fatty acids
to the sn2 position of lyso-phosphatidylinositol (lyso-PI)-containing GPI anchors (Figure 3A,B) [113].
Accordingly, the GUP1 deleted mutant, in contrast to the wild-type strain, was shown to accumulate
lyso-PI and to contain phosphatidylinositol tails with C16 and C18 fatty acids instead of C26, all found
in much smaller amounts compared to wild type (Figure 3B) [113]. The direct involvement of Gup1 as
an enzyme in this process is nevertheless controversial. The wild-type GPI-anchor types can still be
found in the mutant [113]. Concomitantly, it was suggested that Cwh43 was able to catalyse a bypass
to the Gup1-dependent step in inositol phosphoceramide (IPC) tail maturation (Figure 3B) [140,141],
using indifferently PI or Lyso-PI as substrates (Figure 3B). Moreover, the metabolic step associated with
Gup1 is preceded by the transformation of PI into lyso-PI by Per1 (Figure 3B) [139]. In gup1∆ mutants,
the lyso-PI harbours different fatty acid chains, suggesting that the Per1-dependent step is affected by
the deletion of GUP1 as well [113]. Altogether, it is prudent to restrain from naming Gup1 as a mere
GPI remodellase, since this classification does not take into account the multiple phenotypes associated
with the protein, neither does it consider the localisation of Gup1 in the plasma membrane and its
association with the mitochondria. In view of the complexity associated with Gup1 protein so far,
the effects observed in GPI anchor synthesis could be indirect. GPI-anchor remodelling, if confirmed
to be a direct function of Gup1 as an enzyme, will be among the other functions. The enzymes that
catalyse the last steps of PI(4,5)P2 synthesis have associated phenotypes common to the gup1∆ mutant
(Figure 4) (Saccharomyces Genome Database). This could provide the rationale for considering the
possibility of Gup1 acting upstream of these enzymes, at the level of PI production (Figure 3). A change
in PI availability would provide a reason for the changes observed at the level of the ceramide and
diacylglycerol types (Figure 3B). The inosite metabolism was though never studied in this mutant.
3.5. Cell Death
Apoptosis is the most common process of Programmed Cell Death (PCD) in eukaryotes. It is vital
for the fast elimination of useless or injured cells and for the differential development of tissues and
organs. The existence of PCD processes in yeasts is presently unarguable [142]. As mentioned above,
multicellular aggregates of microbial cells, like colonies or biofilms, are spatially organised and require
the specialization of cells differentially localised to ensure supply of nutrients and water to the whole
cell ensemble [143]. PCD occurs in a differentiated way within these aggregates [4]. The underlying
rationale is that older cells of the colony centre that have already multiplied extensively, dying can
contribute to the survival of adjacent cells with limited access to nutrients and water [4].
Several types of stimuli, both endogenous and exogenous, are known to cause yeast cells to enter
a PCD process. H2O2 and acetic acid are major exogenous triggers commonly used to induce apoptosis
in yeast (reviewed by [142]). However, several additional agents have been reported to induce
apoptotic phenotypes, namely, salt stress, ethanol, heavy metals, UV radiation and high temperatures.
Endogenous triggers on the other hand, include defects in N-glycosylation, chromatid cohesion, mRNA
stability and ubiquitination (reviewed by [142]). Moreover, DNA damage (resulting from oxygen
metabolism and ROS generation) and replication failure can stimulate the activation of yeast cell death
programmes. Apoptosis may also play a role in ageing, replicatively [144] or chronologically [145,146].
Gup1 is required for several cellular processes that are related to apoptosis, namely the above
discussed rafts integrity and stability [37], lipid metabolism [55], including GPI anchor correct
remodelling [113], mitochondrial [60] and vacuole [59,147] functions and actin dynamics [57,58].
Accordingly, the deletion of GUP1 induces the hypersensitivity of yeast cells to two known apoptosis
inducing conditions [148], chronological life span (CLS) [149] and acetic acid (reviewed by [150]).
Two apparently contradictory works suggest that the mutation decreases [148], or extends [147] CLS.
In this last work, replicative life span (RLS) is also described to increase in the absence of GUP1.
The main difference between both studies resides in the amino acid availability in the yeast growth
medium, which was four times higher in the study by Li et al. [147] than in the one by Tulha et al. [148].
Considering the above-mentioned suggestions that Gup1 might be implicated in ammonium and TOR
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signalling, which is controlled by nitrogen/amino acid abundance [79], the mutant will likely respond
differently to apoptosis induction in either cultivation condition.
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Figure 4. Phenotypes associated to the enzymes known to catalyse the steps from PI to PI(4,5)P2 in S. 
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mitophagy. * Preliminary results [45]. 
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type undergoes a necrotic-like cell death process [148]. This is inferred from the absence of typical 
apoptotic features: (a) maintenance of the membrane integrity, (b) phosphatidylserine 
externalisation, (c) depolarisation of mitochondrial membrane, and (d) chromatin condensation. 
Moreover, preliminary assays on autophagy inducing conditions, i.e., nitrogen starvation, show that 
the deletion of GUP1 causes a clear decrease of autophagic activity as determined by GFP-Atg8 
(autophagy-related 8) degradation assay [45,151]. 
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that relate with the ability to invade and adhere. At this level, Candida species, namely C. albicans, 
have been more studied than S. cerevisiae, mainly due to their pathogenicity.  
C. albicans is a commensal constituent of normal human microflora that acts as an opportunistic 
pathogen causing infections such as denture stomatitis, thrush and urinary tract infections, but can 
also provoke more severe systemic infections, in particular in immunocompromised individuals 
[153,154]. Among the underlying virulence mechanisms, the most well studied so far is probably the 
morphological switch from budding yeast to filamentous fungus, which, together with cell surface 
expression of adhesins and invasins (reviewed by [153]), allows colonisation of host tissues and their 
aggressive invasion, eventually overcoming the endothelial barrier [155]. The infection-associated 
yeast fast reproduction promotes formation of biofilms, not only on human and other organism 
tissues, but also on inert surfaces from clinical devices [154,156], constituting a major threat for 
hospitalised patients, in particular if immunocompromised. 
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On the other hand, in the presence of lethal concentrations of acetic acid, gup1∆ unlike the wild
type undergoes a necrotic-like cell death process [148]. This is inferred from the absence of typical
apoptotic features: (a) maintenance of the membrane integrity, (b) phosphatidylserine externalisation,
(c) depolarisation of mitochondrial membrane, and (d) chromatin condensation. Moreover, preliminary
assays on autophagy inducing conditions, i.e., nitrogen starvation, show that the deletion of GUP1
causes a clear decrease of autophagic activity as determined by GFP-Atg8 (autophagy-related 8)
degradation assay [45,151].
3.6. Differentiation and Morphology
The Hedgehog pathway has well-established roles in the development and maintenance of high
eukaryote differentiation. In yeasts, changes in morphology and differentiation occur at two very
distinct levels. Individual cells can differentiate by changing shape, shifting from yeasts to very
elongated polarised cells of true or pseudo hyphae. Colonies can display multiple 3D shapes [152]
that relate with the ability to invade and adhere. At this level, Candida species, namely C. albicans,
have been more studied than S. cerevisiae, mainly due to their pathogenicity.
C. albicans is a comm nsal constitue t of normal human microflora that acts a an opportunistic
pathogen causing infec ions such as denture stomatitis, thrush and urinary tract in ections, but can also
provoke more severe systemic infections, in particular in immunocompromis d individual [153,154].
Among the underlying virulence mechanisms, the most well studied so far is probably the
morphological switch from budding yeast to filamentous fungus, which, together with cell surface
expression of adhesins and invasins (reviewed by [153]), allows colonisation of host tissues and their
aggressive invasion, eventually overcoming the endothelial barrier [155]. The infection-associated
yeast fast reproduction promotes formation of biofilms, not only on human and other organism tissues,
but also on inert surfaces from clinical devices [154,156], constituting a major threat for hospitalised
patients, in particular if immunocompromised.
C. albicans has only one GUP orthologue: caGUP1. caGup1 has been implicated in C. albicans
virulence [29]. Accordingly, the cagup1∆ null mutant [157] was strongly affected in the ability
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to develop hyphae, to adhere, invade and form biofilm, and its colonies exhibited aberrant
morphology/differentiation patterns [29]. Interestingly, M. musculus HHATL cDNA was able to
complement the cagup1∆ null mutant morphogenic defects associated with colony invasive growth
(Figure 5) [29]. Preliminary data suggests that the hyphae development defects of the mutant can
be reverted although not completely by S. cerevisiae GUP1, as well as the human HHATL and
D. melanogaster RASP(HHAT) [158]. This partial reversal corresponds to a notorious cell elongation
into pseudohyphae instead of true hyphae. The amino acid sequences of C. albicans and M. musculus
Gup proteins share only 20% similarity, whereas S. cerevisiae and C. albicans GUP1 sequences share
58%. Moreover, as mentioned above, the two key MBOAT amino acid residues differ in yeast Gup1/2
and mammalian HHAT(L). It remains to be seen in the future how far the high eukaryotes HHAT(L)
ability goes in complementing yeast phenotypes, namely using alternative expression strategies and if
the substitutions in the MBOAT residues play a role.
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to a proto-tissue. Traditionally, C. albicans or other closely related yeasts have been extensively used
to study biofilm formation. S. cerevisiae can be used to mimic biofilm by promoting its growth
onto large communities such as giant colonies or mats [2,161–163]. Analogously to the tissues
from higher eukaryot s, these multicellular aggregates depend on the production and secretion
of extrac llular matrix (ECM) [163]. In S. cerevisiae, this w s shown t be made of two different
polysaccharides [10] and to harbour a large and abundant proteome composed of 684 well-identified
proteins belonging to very different functional classes [11]. The deletion of GUP1 in S. cerevisiae
provokes a profound difference in the composition of the secretome, yielding a sludgy-textured ECM
that lost one of the polysaccharides present in wild-type ECM and harbours approximately 15% less
proteins, 26% of which are not found in the wild-type ECM [10,11]. Additionally, DIGE analysis
identified as well common proteins though present in statistically different amounts [11]. Among the
missing proteins, there are some key regulators of metabolic pathways, namely Fbp1, Pyc2 and P c5/6
from glycolysis/gluconeogenesis/fermentation; important effectors in cytoskeleton organization like
Tub2, Ent2/3, Rvs161 or VPS; stress response and secretory pathway proteins like Vma6/7, Vph1 or Ctt1
and Ecm4/38; and proteins involved in ubiquitination and sumoylation [11]. Moreover, the selective
presence in the wild-type ECM of alpha-saccharides remodelling enzymes, such as Glc3 1,4-α-glucan
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branching enzyme, Mnn2 α-1,2-mannosyltransferase and Sga1 α-glucoamylase, suggest the presence
of α-based polysaccharides in opposition to the cell wall beta sugars backbone. These seem to be
important for ECM texture as inferred from the absence of these enzymes in gup1∆ mutant ECM [11].
On the other hand, the mutant ECM comprises a great number of proteins involved in cell wall
remodelling that were not found in the wild-type ECM, including the homologous GPI-anchored
putative mannosidases Dcw1 and Dfg1, required for cell wall biosynthesis, Utr2, Kre6 and Krt2 proteins
involved in the biosynthesis of β-glucans, Pir1 and Pir2 proteins involved in stabilization of the cell
wall, and GPI-anchored protease Yps1 required for cell wall growth and maintenance. Clearly GUP1
considerably affects the secretion of both glycosides and proteins into the yeast ECM.
4. Proteins Interacting with Yeast Gup1 and Gup2
Although much work is still necessary to fully identify the full interactome of Gup1/2 proteins in
yeast, these have putative physical partners, predicted by whole genome screenings, or ascertained
in particular single-gene studies in the case of Gup1 (Table 3). Gup2 partners include interesting
proteins (Table 3), like Ste2, the receptor for α-factor, a yeast pheromone that initiates signalling
response to mating by interacting both with the pheromone and a heterotrimeric G-protein [164].
On the other hand, Gup1 co-localises with Mep2 [165] and Por1 [45] and immunoprecipitates with
Por1 and Pil1 [45]. Pil1 is a major constituent of eisosomes, and Por1 is the mitochondrial VDAC
(voltage-dependent anion channel). The nature of these two last interactions remains unknown
for the time being. Biochemically, Por1 interacts with Sfk1, a suppressor of the calcineurin inhibitor
immunosuppressant drug FK506, by which it modulates the mitochondrial ionic balance [166]. gup1∆ is
resistant to FK506 [65], suggesting that Gup1 might be necessary for the interaction of Por1 with Sfk1,
which would therefore be impaired from inhibiting FK506 in the mutant.
Mep2 belongs to a highly conserved Mep/Amt/Rh superfamily that also includes the Rh
blood-group human antigens [167]. There are three well-characterised Mep-type ammonium
transporters in S. cerevisiae, Mep1, 2 and 3 [168]. S. cerevisiae Mep2 and its positive regulator Npr1
kinase [169,170], and C. albicans Mep1 and Mep2 [171], are indispensable for differentiation, i.e.,
for true or pseudo-hyphae formation respectively. Mep2 has accordingly been associated with TORC1
signalling, implicating in CLS and ageing [172]. Moreover, Mep2 promotes activation of the PKA
pathway by ammonium on nitrogen-starved cells [173]. GUP1 is required for proper distribution of
Mep2 over the plasma membrane, while another protein that also putatively interacts with Gup1,
Vma4 (Table 3), is required for Mep2 expression [165]. In gup1∆, Mep2 is localised in patches instead
of homogenously over the entire plasma membrane, while both transport and signalling associated
to Mep2 function are increased [165]. Although these authors suggest that the effect of Gup1 on
Mep2 might be indirect in view of the multiple phenotypes associated with GUP1 gene involving
plasma membrane, rafts and wall, it seems more likely that Gup1 directly negatively regulates Mep2.
This would justify the higher Mep2-mediated transport and signalling observed in the strain deleted
in GUP1 (with Mep2 uninhibited). However, Mep2 is released naturally onto the wild-type yeast
ECM [11], suggesting that the picture is much more complex.
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Table 3. Gup1 and Gup2 ascertained and predicted physical partners.
Partner Assay Type of Study Key Reference Assigned Function
Gup1
Fet3 PCA HTP [174] Iron-O2-oxidoreductase; multicopper oxidase that oxidizes ferrous (Fe
2+) to ferric iron (Fe3+) for subsequent cellular
uptake by transmembrane permease Ftr1.
Frk1 BA HTP [175] Protein kinase of unknown cellular role; interacts with rRNA transcription and ribosome biogenesis factors, and thelong chain fatty acyl-CoA synthetase Faa3p.
Hek2 AC HTP [176] RNA-binding protein involved in asymmetric localization of ASH1 mRNA; represses translation of ASH1 mRNA, aneffect reversed by Yck1-dependent phosphorylation; regulates telomere position effect and length.
Mep2 2H/Co-L Single study [165] NH4+ permease; regulation of pseudohyphal growth; expression regulated by nitrogen catabolite repression (NCR).
Msc7 PCA HTP [177] Cytoplasmic protein of unknown function.
Nab2 AC HTP [178] Nuclear poly(A)-binding protein; required for nuclear mRNA export and tail length control.
Pil1 Co-IP Single study [45] Eisosome core component; detected in phosphorylated state in mitochondria; phosphorylated upon Pkc1hyperactivation in a Slt2p MAPK-dependent fashion.
Por1 Co-IP/Co-L Single study [45] Mitochondrial voltage-dependent anion channel (VDAC); required for maintenance of mitochondrial osmotic stabilityand membrane permeability; couples the glutathione pools of the intermembrane space and the cytosol.
Sat4 BA HTP [175] Ser/Thr protein kinase involved in salt tolerance; functions in regulation of Trk1-Trk2 potassium transporter.
Vtc4 PCA HTP [174] Vacuolar membrane polyP polymerase; subunit of the vacuolar transporter chaperone (VTC) complex; regulatesmembrane trafficking; role in non-autophagic vacuolar fusion.
YHL042W PCA HTP [174] Putative protein of unknown function.
Gup2
Aqy1 PCA HTP [174] Spore-specific aquaporin.
Aus1 PCA HTP [179] Plasma membrane sterol transporter of the ATP-binding cassette family; required, along with Pdr11, for uptake ofexogenous sterols and their incorporation into the plasma membrane.
Hsp30 PCA HTP [174] Negative regulator of the H(+)-ATPase Pma1; stress-responsive; induced by heat shock, ethanol, weak organic acid,glucose limitation, and entry into stationary phase.
Ifa38 PCA HTP [174] Microsomal beta-keto-reductase; mutants exhibit reduced VLCFA synthesis, accumulate high levels ofdihydrosphingosine, phytosphingosine and medium-chain ceramides.
Nam7 AC HTP [180] ATP-dependent RNA helicase.
Pdr10 PCA HTP [179] ATP-binding cassette (ABC) transporter; multidrug transporter involved in the pleiotropic drug resistance network;regulated by Pdr1p and Pdr3p.
Pho88 PCA HTP [174] Probable membrane protein involved in phosphate transport; role in the maturation of secretory proteins.
Sss1 PCA HTP [174] Subunit of the Sec61 translocation complex (Sec61-Sss1-Sbh1); this complex forms a channel for passage of secretoryproteins through the ER membrane.
Ste2 PCA HTP [174] Receptor for α-factor pheromone; interacts with both pheromone and a heterotrimeric G-protein to initiate thesignaling response that leads to mating.
HTP: high throughput; PCA: protein complementation assay; AC: affinity capture (RNA); BA: biochemical activity; 2H: two-hybrid; Co-IP: co-immunoprecipitation;
Co-L: co-localization.
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5. Gup1/2 Homologues from High Eukaryotes
5.1. Hedgehog Pathway
Yeast Gup1 and its close homologue Gup2 share significant sequence homology with proteins
belonging to higher eukaryotes, from Caenorhabditis elegans, to Drosophila melanogaster, to mammals.
All of those proteins, identical to Gup1/2 from yeast [23], were identified as members of the membrane
bound O-acyltransferase (MBOAT) family based on their sequence homology. They all share two
highly conserved regions of amino acids: one hydrophobic region containing an invariant histidine
and a region composed of moderately hydrophobic amino acids that surround a well-conserved
asparagine/aspartic acid residue [23]. The only exception found so far is the mammalian homologue
of Gup1 HHATL (Hedgehog acyltransferase-like), in which the homologous regions are maintained,
but the conserved histidine residue is replaced with a leucine. Thanks to the high degree of conservation
of these two regions, at least 11 members of the MBOAT family have been identified so far in the
human genome [38].
MBOAT family proteins also share a common topology. They all have 8–12 TMDs and localise
in the ER or Golgi [38,181,182]. HHAT was first predicted to have eight TMDs [40], but this topology
seems inconsistent when compared to other members of the MBOAT family. Specifically, the MBOAT
signature amino acid residues would be located in the cytoplasm, which would be a feature unique to
HHAT among all the other MBOAT members [42]. Recently, the topology of human HHAT has been
further investigated using different prediction software, and the results obtained by two independent
research groups showed that HHAT contains 10 TMDs and two re-entrant loops. The invariant His is
located in the lumenal side of the endoplasmic reticulum, whereas the Asp residue is on the opposite
side [42,183]. Conceivably, HHATL should have a similar structure, due to the high sequence similarity.
Most members of the MBOAT family catalyse the transfer of long chain fatty acids to hydroxyl
groups of other lipophilic molecules [184–186], or the formation of wax esters [187]. They are
categorised into three subgroups based on their biochemical reaction, due to the variety of processes
in which they are involved [38]. Mammalian HHAT and its fly counterpart, together with Porcupine
and Ghrelin O-acyltransferase (GOAT), belong to the group involved in the acylation of secreted
proteins [38,182]. In particular, HHAT is the protein responsible for the N-palmitoylation of the
Hedgehog morphogens [41,42] and Spitz (also known as Torpedo or DER), a fly protein homologous
to TGF-alpha, that either acts as a secreted or as a cell-bound EGFR ligand [42]. M. musculus and
human HHATL, as mentioned above, have the invariant His necessary for the palmitoylation activity
of HHAT replaced by a Leu [40,42]. It is, therefore, expected to not act as an acyltransferase, although it
was found to co-localise with both HHAT and Sonic in the ER [21]. It was shown that HHATL interacts
directly with Shh decreasing the efficiency of Shh palmitoylation [22], being proposed as a negative
regulator of the HHAT-driven N-palmitoylation of Shh and of the Hh pathway. However, the precise
mechanism of action has yet to be described.
In mammals as well as in Drosophila, HHAT promotes Hedgehog secreted morphogens
N-palmitoylation [20–22,40]. Hh morphogens are diffusible proteins involved in long distance
cell-cell communication, playing fundamental roles in embryonic development, patterning and cellular
differentiation [188–191], as well as in adult tissue homeostasis and cancer [192]. Proper signalling
is achieved by a specific gradient of Hh morphogens concentration from the cells that produce it to
those destined to bind them [169,193–195]. Hh post-translational lipophilic modifications have a key
role in maintaining the protein concentration gradient, influencing the long range signalling [196,197],
which depends on the formation of diffusible multimeric forms [198–200]. On the other hand, secretion
of Hh morphogens might operate through several mechanisms. One is the formation of specific fat
body-derived diffusible lipoprotein particles [196,201], which in Drosophila largely depends on lipid
rafts [202–204]. Another mechanism is an exosome-mediated pathway [205,206]. Exosomes derive
from the endocytic compartment where vesicles are packed [207]. Yeasts also produce and secrete
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exosomes [208,209], which proteome was characterised in C. albicans [210,211]. Still there is no idea
regarding their biological roles.
In mammalian cells, Hedgehog responsive cells activate transcription through Gli1. This occurs
in the Hh responding cells by the triangulation Hh ligand-Ptch1-Smo. Gli1 can be activated
by Smo-independent mechanisms, increasing Hh signalling even in the absence of the Hh
ligand. This non-canonical activation of Gli1 was described in association with oesophageal
adenocarcinoma [212]. In that case, Gli1 is controlled by a TNFα-derived TORC1/S6K1 pathway.
TORC1 promotes the phosphorylation of Gli1 (at S384) by S6K1, freeing it from SuFu and easing
the entrance to the nucleus. Additionally, TORC2 promotes the stabilisation of Gli1 by keeping it
phosphorylated (at S230) through the action of AKT [212,213]. AKT commands a star-type pathway and
demands intracellular signalling by phosphoinosides, from which the designation of PI3K-PKB/AKT
pathway (reviewed by [214]). Other possible cross-talks with Hedgehog have been suggested to
operate at the level of Gli1 activation: MAPK/ERK [215] and KRAS [216].
5.2. HHAT(L) Proteins Expression and Associated Pathologies
Palmitoylation at the N-terminal domain of Hedgehog proteins is necessary for the proper Hh
signalling at both long and short range [217]. It was shown in vitro that palmitoylated forms of Shh
are 40–160-fold more active compared to unmodified Shh [218]. Palmitoylated Sonic Hh is required
for the formation of multimeric complexes that are fundamental for extracellular migration [199].
Therefore, the proper functionality of HHAT is fundamental for maintenance of the correct Hh function.
This should stand for the Hh pathway function, namely during embryogenesis. Accordingly, HHAT
loss of function by a single G287V missense mutation resulted in serious sex development defects [219].
In general, Hh signalling malfunction, causes severe and often life-threatening developmental disorders
such as holoprosencephaly, craniofacial defects and skeletal malformations [31,220–222].
In human tissues, the HHAT(L) picture appears somewhat more complex than predicted [22].
The HHATL gene is expressed in very few tissues and in different amounts: heart > skeletal muscle
> brain [34,35,223]. Actually, the gene maps to a locus of dilated cardiomyopathy (CMD1E/OMIM
601154), a disorder characterised by ventricular dilation and impaired systolic function, resulting in
congestive heart failure and arrhythmia, eventually causing premature death that also harbours another
gene encoding a cardiac muscle Na+ channel (SCN5A/HH1). Despite this association, the absence
of HHATL disease-specific mutations in a cohort of 48 patients [34], leaves no clear indication that
HHATL might be responsible for the disease.
It has been estimated that 25% of all human tumours required Hh signalling to maintain tumour
cell viability [167]. Corrupted Hh signalling, namely through over-activation, underlies many types
of cancer, including small and non-small cell lung cancer, squamous cell and basal cell carcinomas
and myeloid leukaemias [224–228]. The importance of Hh signal palmitoylation on this regard has
recently been demonstrated. The knockdown of HHAT caused in vitro reduced proliferation and
invasiveness of human pancreatic ductal adenocarcinoma [229]. Therefore, it is conceivable that
blocking the Hedgehog pathway using HHAT inhibitors may block tumour progression [230,231].
Moreover, HHATL transfected cells presented lower capability of cell proliferation, invasion and
tumorigenicity, supporting the notion that the protein might function as a tumour suppressor [36].
This function is compatible with the negative regulation of HHAT-mediated Hh palmitoylation
described for HHATL [22]. The reason why this gene is only expressed in few tissues appears
intriguing. Other works reported the expression of KIAA1173 (another GUP1/HHATL alias—Table 1)
in normal skin [232] and nasopharyngeal mucosa [36], and its extreme down-regulation in cells of
skin squamous cell carcinoma [232]. Still, the KIAA1173 protein is N-172 amino acids shorter than
the cardiac isoform above-mentioned [34], suggesting that the HHATL ORF might undergo extensive
RNA or protein splicing and perform different roles in different tissues.
The HHAT gene has also been associated with type 2 diabetes [233]. Its changed expression
was found in patients undergoing bariatric surgery [233], further suggesting a correlation with
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glucose homeostasis and therefore obesity. Diabetes mellitus and obesity are closely related [234],
through deficient glycerol consumption by glycerol kinase [235] and deficient tissue regulation of
glycerol transport by aquaglyceroporins [236]. This once again raises the notion that in yeasts Gup1
implicates in glycerol transport, consumption and production for osmoregulation purposes [19,28]
and that it apparently connects nutrient regulation to morphogenic-related Hedgehog-like phenotypes,
through a signalling entanglement between the CWI/Pkc1, TORC2/YPK TORC1/Pkh1/2 and
HOG/Sho1 pathways.
6. Similarity Analysis of the GUP/HHAT(L) Amino Acid Sequences
Gup proteins from both yeast and higher eukaryotes belong to the MBOAT superfamily of
membrane-bound O-acyltransferases, although only the mammalian HHAT has been assigned a
function as an enzyme performing the palmitoylation of the Sonic Hedgehog ligand [21]. All eukaryotes
have at least one such gene/protein. Therefore, the databases present an extremely large number of
sequences designated as Gup or HHAT(L). This generalised presence does not necessarily mean that
the amino acid sequence is highly conserved. Multiple sequence alignment similarity matrices were
built using Clustal Omega [237], based on the accession numbers available at UniProt database and
confronting them with NCBI available sequences (Supplementary File S1). These were grouped in a
simple manner: yeasts, filamentous fungi, mammals, fish, teleostomi, reptiles, birds, amphibian, insects,
nematodes, testudines and arthopoda (Supplementary File S2). A few isolated organisms presenting
GUP/HHAT(L) sequences were grouped as others in Supplementary File S2. Gup1/HHATL is absent
from nematodes and insects, while Gup2/HHAT is absent from reptiles, amphibian, testudines,
teleostomi and Zea mays, the only plant where a Gup amino acid sequence was so far identified.
Within each matrix, the percentage of similarity varied between two extreme values (shadowed
in File S2). Notably, Gup1/HHATL sequences from nematodes are the most diverse. Generally,
Gup1/HHATL sequences are less diverse than the Gup2/HHAT, which is perceptible in the respective
cladograms (Figure S1A,B) built using Mega 7 (Molecular Evolutionary Genetics Analysis) [238]. Still,
the difference in similarity between the Gup1/HHATL and Gup2/HHAT sequences is very small.
As an example, we present in Table 4 the similarity matrix between the better studied Gup proteins:
S. cerevisiae Gup1 and Gup2, C. albicans Gup1, M. musculus HHATL and HHAT, H. sapiens HHATL and
HHAT and D. melanogaster RASP/HHAT. The sequence similarity presented is very high. M. musculus
HHAT shares 20% similarity with yeast Gup2 and 19.3% with yeast Gup1, while HHATL shares 21.9%
similarity with yeast Gup2 and 20.7% with yeast Gup1. The frontier between proteins considered
HHAT and HHATL is very narrow. Moreover, some sequences actually appear to be too different from
the yeast Gup proteins to even be considered as such (Supplementary File S2).
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Table 4. Similarity matrix between the most studied GUP proteins.
C. albicans
SC5314 Gup1
S. cerevisiae
S288c Gup1
S. cerevisiae
S288c Gup2
D. melanogaster
Gup2/RASP
M. musculus
Gup1/HHATL
H. sapiens
Gup1/HHATL
M. musculus
Gup2/HHAT
H. sapiens
Gup2/HHAT
C. albicans SC5314 Gup1 100.00 57.64 47.02 16.63 19.15 18.45 18.49 18.77
S. cerevisiae S288c Gup1 57.64 100.00 56.61 17.84 20.70 20.45 19.30 19.80
S. cerevisiae S288c Gup2 47.02 56.61 100.00 17.80 20.92 20.20 20.00 21.07
D. melanogaster Gup2/RASP 16.63 17.84 17.80 100.00 21.62 21.14 25.94 26.58
M. musculus Gup1/HHATL 19.15 20.70 20.92 21.62 100.00 90.07 28.16 27.92
H. sapiens Gup1/HHATL 18.45 20.45 20.20 21.14 90.07 100.00 28.33 27.86
M. musculus Gup2/HHAT 18.49 19.30 20.00 25.94 28.16 28.33 100.00 82.91
H. sapiens Gup2/HHAT 18.77 19.80 21.07 26.58 27.92 27.86 82.91 100.00
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7. Conclusions
Paracrine signalling has not yet been recognised as occurring in microbial communities. However,
the notion that microbes multicellular aggregates can be regarded as tissues, suggested for the
first time by Shapiro in 1988 (reviewed by [239]), predicts that each individual cell does not live
exclusively in response to environmental stimuli, as happens in planktonic life, but must involve
cell–cell communication. It remains unclear whether this may happen through a diffusible chemical,
like ammonia [12,240,241] or the quorum-sensing chemicals [13,14], or through a peptide signal like
in higher Eukaryotes. The large number and diverse proteome from the yeast ECM [11,210,211]
hampers the identification of a putative peptide signal. Additionally, the also high number of proteins
identified as being differently expressed in the GUP1-deleted mutant ECM compared to the wt strain,
does not allow the suggestion of a candidate [11]. Nevertheless, the fact that all Eukaryotes present
a Gup/HHAT(L) protein suggests a conserved mechanism in which these proteins may participate.
One should, however, not discard the hypothesis that proteins from the same group might perform
very different roles in different organisms. The plethora of phenotypes from the yeast gup1∆ mutant,
and the multiple localisation of the Gup1 protein, actually favour this as having multiple roles.
The most prominent Gup1 and Gup2 localisation is the plasma membrane [19,41,45].
In tmammalian or fly cells, HHAT is almost exclusively located in the ER, while the localisation
HHATL is still scarcely documented. Data suggest that yeast Gup1 is, or locates at, a hub between
CWI/Pkc1, TORC2/YPK, TORC1/Pkh1/2 and HOG/Sho1 pathways, controlling response to nutrients
and stress and morphogenic-related Hedgehog-like phenotypes. Therefore, it is not surprising that
GUP1 deletion-associated phenotypes cover a vast number of pathways controlling basic processes of
yeast life (summarised in Figure 6), namely associated with growth and development and that the
deletion of the gene does not, in spite of its central role, become lethal. Altogether only fitness appears
to be decreased in most of the environmental conditions studied (temperature, pH, stress and so on).
Importantly, most of the phenotypes caused in yeast by the deletion of GUP1 or GUP2 are
associated with the GUP1 deletion, in opposition of mammalian and fly cells in which case the
information available almost exclusively regards Gup2/HHAT (Figure 6). This does not mean that
Gup2 has no function in yeasts. In mammals, the Gup2/HHAT is the enzyme that performs the
palmitoylation of the Hh signal [21], while Gup1/HHATL acts as an inhibitor of that palmitoylation [21]
through an as yet unknown mechanism. If that would be the case for yeasts, Gup2 could be performing
a role that is inhibited by Gup1 and, therefore, all of the phenotypes associated with the deletion of
GUP1 would actually derive from the uninhibited function of Gup2.
A last comment goes to nomenclature. It is important that Gup proteins are not further taken as
glycerol transporters. This mistaken allusion has equally appeared in the literature dedicated to yeasts
or mammalian cells. Due to the poor understanding of these proteins, the Gup1 from S. cerevisiae has
even been cloned and heterologously expressed as if it were the actual glycerol permease (e.g., [27]).
Moreover, careful naming would be recommended in the fields of research using high eukaryotes,
in view of the extreme similarity between HHAT and HHATL and between these and the original
S. cerevisiae Gup1 and Gup2 proteins. In order to avoid the misguidance generated by the multiple
designations (Table 1) we propose a single notification. Based on the examples of the Ras and TOR
proteins, for which the name used in the higher eukaryotes and the numeration of yeasts were
combined, we propose that HHAT1 and HHAT2 are consistently adopted hereon to be designated
Gup1/HHATL and Gup2/HHAT, regardless of the biological system under study.
A lot is still required to unveil the true nature and biological function of the Gup proteins.
The results so far contribute to stress that studies based on either yeasts or higher eukaryotes are
equally important and complement themselves. In particular, in the near future, the search for the
molecular partners/targets of the Gup proteins in yeast will be important, along with an understanding
of why Gup1/HHATL is only present and important in a few adult human tissues, the physiology of
which does not straightforwardly relate to the Hedgehog pathway.
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Nomenclature
According to the rules from Yeast scientific nomenclature, genes, proteins and mutants are presented in,
capitals/italic (ex.: GUP1), title case (ex.: Gup1), and lower case/italics (ex.: gup1∆), respectively. In the
case of other model organisms, proteins and genes are presented as in the corresponding literature.
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